The biggest challenge will be to encourage providers of antibiotics to change their behavior. This will require measures such as accreditation, modification of payment mechanisms, and the involvement of intermediary organizations to give technical support and monitor performance.
Algumas inovações nas embalagens, talvez oferecendo ciclos completos de combinações adequadas de drogas, poderiam simplificar as decisões de tratamento.